Frontiers of novel drug targets in disease
-
Chair(s):
Michael Spedding,
President, Spedding Research Solutions SAS, Le Vesinet, FranceProfessor Yongxiang Zhang,
Beijing Institute of Pharmacology and Toxicology, Beijing, China -
Session description:
The novel drug targets in the therapy for mood disorders
Professor Jianguo Chen
Vice President, Huazhong University of Science and Technology, ChinaDevelopment of a Novel Allosteric c-RAF Inhibitor Against KRAS-driven Pancreatic Cancer
Dr Connor Mcleod Blair
Postdoctoral Research Associate, University of Glasgow, United KingdomOral communication speaker - to be confirmed in 2023.
GM1 and its oligosaccharides: brain penetration and novel therapies for Parkinson's and Cystic Fibrosis
Dr Elena Chiricozzi
Assistant Professor, University of Milano, ItalyPharmacological target identification strategy of active natural products
Dr Kewu Zeng
Tenure-Track Assistant Professor, Peking University Health Science Centre, China
Speakers
-
Dr Connor Macleod BlairPostdoctoral Research Associate, University of Glasgow, United Kingdom
-
Dr Elena ChiricozziUniversità degli Studi di Milano, Milano, Italy
-
Dr Kewu ZengTenure-Track Assistant Professor, Peking University Health Science Center, Beijing, China
-
Professor Jianguo ChenHuazhong University of Science and Technology, Wuhan, China
Leave A Comment